<http://schema.org/url>
<https://www.genengnews.com/>
<http://www.genengnews.com/keywordsandtools/email/gen-news-highlights/allergan-licenses-molecular-partners-phase-ii-eye-disease-protein-therapeutic-for-45m/22960/>